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An Mll-Dependent Hox Program
Drives Hematopoietic Progenitor Expansion
of the yolk sac, the first site of hematopoiesis in mam-
mals [3, 4]. To perform a quantitative analysis of hemato-
poietic development in Mll-deficient EBs, we used an
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Development of Hematopoietic PopulationsSummary
in Mll/ EBs
Unfractionated Mll-deficient EBs and yolk-sac cellsChromosomal translocations disrupting the Mixed lin-
exhibited reduced hematopoietic potential in colonyeage leukemia (Mll) gene result in leukemia, with aber-
assays (unpublished data and [5]), prompting us to de-
rant expression of some native Mll target genes (re-
termine whether transitional hematopoietic populations
viewed in [1]). The Mll gene encodes a Trithorax-group
developed within Mll/ EBs. In the first 4 days of em-
chromatin regulator that is essential for the develop- bryoid body development, expression of the receptor
ment of hematopoietic stem cells (HSCs) during em- tyrosine kinase Flk-1 (VEGFR-2) defines one of the earli-
bryogenesis [2]. Like Trithorax, MLL positively regu- est mesodermal derivatives harboring all primitive and
lates clustered homeodomain or Hox genes, yet the definitive hematopoietic potential [6]. This population
role of Hox genes collectively in the development of the includes the hemangioblast, a precursor of primitive and
mammalian hematopoietic system has been difficult to definitive hematopoietic cells as well as vascular endo-
ascertain because of redundancy among Hox para- thelium [7]. Flk-1 cells developed in Mll/ EBs to the
logs. Here, we show that in the absence of MLL, early same extent as wild-type and Mll / cells; in fact, this
hematopoietic progenitors develop despite reduced population accumulated slightly earlier in Mll/ EBs
expression of HoxA, HoxB, and HoxC genes. However, (Figure 1C). Thus, the development of this early meso-
these progenitors exhibit a marked reduction in their dermal derivative with both hematopoietic and endothe-
ability to generate hematopoietic colonies, a subse- lial potential is not dependent on Mll.
quent process requiring cell division and differentia- Next, we examined the appearance of subsequent
tion. Reactivation of a subset of Hox genes or, remark- committed hematopoietic populations. The frequency
ably, reexpression of a single Hox gene in Mll-deficient of colonies with a primitive erythroid morphology was
progenitors rescued hematopoietic-colony frequency not reduced by MLL deficiency (unpublished data). To
and growth. In contrast, expression of other MLL target assess the development of cells with definitive hemato-
genes such as Pitx2 or expression of anti-apoptotic poietic potential, we performed a time course experi-
BCL-2 failed to rescue hematopoietic-colony frequency. ment to analyze the surface expression of c-Kit and
Furthermore, our results highlight a shared function CD41. Cells coexpressing these markers from day 6 EBs
of Hox proteins at this point in the development of the are highly enriched for definitive colony-forming activity
hematopoietic system. [8] and have lost endothelial and primitive erythroid po-
tential [9]. Notably, Mll/ EBs generated c-Kit/CD41
cells in similar numbers and with kinetics indistinguish-Results and Discussion
able from those of control EBs (Figures 2A–2B). How-
ever, despite the apparently normal development ofEmbryoid Body Formation and Growth
c-Kit/CD41 cells in Mll/ EBs, these cells were defi-Embryonic stem (ES) cells differentiate in vitro to form
cient in producing hematopoietic colonies (Figure 2C).embryoid bodies (EBs), or organized aggregates within
Therefore, the development of definitive hematopoieticwhich hematopoietic development proceeds in a syn-
c-Kit/CD41 cells appears to be the last point at whichchronous manner. The developmental kinetics of hema-
Mll-deficient cells differentiate normally. Thus, Mll playstopoietic commitment within EBs generally parallels that
a nonredundant, essential role in hematopoiesis, and
this role is independent from the early steps of hemato-
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hematopoiesis in gain-of-function experiments [10–13];
therefore, we examined this class of genes as putative
effectors of the Mll-dependent step in hematopoiesis.
We first analyzed the Mll dependence of several repre-
sentatives of the HoxA and HoxB gene clusters because
several of these genes are selectively expressed in de-
veloping hematopoietic populations [14]. To minimize
differences due to clonal variation, we compared pairs of
Mll/ and Mll/ ES cell clones derived from a common
subclone in a time course experiment and monitored
relative gene expression levels by using quantitative
PCR (Figure 3). Peak expression levels occurred at dif-
ferent time points depending on the gene analyzed, but
Mll expression itself differed only 1.5- to 2-fold through-
out the 10 day time course (Figure 3K). We found that
the induction of Hoxa7, Hoxa9, and Hoxa10 was dramati-
cally reduced in Mll-deficient EBs (as much as 500-fold
reduced for Hoxa9; Figure 3B). Similarly, several HoxB
cluster genes were reduced in Mll/ EBs at all time
points (Hoxb4, Hoxb5, Hoxb6, Hoxb8, Figures 3E–3H)
or at select time points (Hoxb3; Figure 3D), as well as
within sorted day 6 c-Kit/CD41 EB cells; see Figure
S1 in the Supplemental Data available with this article
online).
The tested HoxC cluster gene, Hoxc6, exhibited a
more modest reduction (2- to 5-fold; Figure 3I) through-
out differentiation of Mll/ EBs relative to the Mll/
control. In patients with B or T cell acute lymphoblastic
leukemia (ALL), Hoxc6 is consistently overexpressed in
leukemic cells harboring an MLL translocation [15, 16],
suggesting that, like Hoxa9, it may be a transcriptional
target for both MLL and MLL fusion oncoproteins. Pitx2
(also known as ARP-1 or Reig-1 [17, 18]), a homeodo-
main gene shown to be a direct transcriptional target
of MLL [19], was also reduced 3- to 6-fold during the
differentiation of Mll/ EBs (Figure 3L). Pitx2 was identi-
fied as a gene whose expression was dependent on
MLL by the use of an ES cell line homozygous for a
distinct Mll disruption allele [20].
We evaluated the Hox cofactors Meis-1 and Pbx-1 to
assess whether compensatory changes in the expres-
sion of these genes might affect Hox activity. Further-
more, Meis-1 is overexpressed in leukemic cells harbor-
ing MLL translocations and in cell lines immortalized by
MLL fusion proteins [16, 21]. We found that neither gene
was significantly affected by Mll deficiency (Figure 3J
and Figure S2), suggesting that genes such as Meis-1
represent selective targets of MLL fusion oncogenes or Figure 1. Mll/ ES Cells Grow Normally and Differentiate into EBs
are upregulated as complementary secondary events in Embryonic stem cells of the genotypes indicated were allowed to
differentiate and were photographed under phase contrast opticsleukemic cells.
(A); alternatively, triplicate samples were harvested for cell enumera-In sum, at least ten Hox genes, as well as Pitx2, exhib-
tion from each clone tested (B). Wild-type, dashed line; Mll/ EBs,ited reduced expression in Mll-deficient EBs. MLL binds
blue lines; and Mll/ EBs, red lines. Error bars reflect the standarddirectly to the regulatory elements of two of these genes
deviation from the average of triplicate samples. (C) Flow cytometry
[19, 22], but it remains to be determined whether the analysis of Flk-1 expression. ES cells were allowed to differentiate
reduced expression of the other Hox genes is direct or for the indicated number of days (x axis), cells were dissociated
through intermediary proteins. Despite this widespread with trypsin, and the percent Flk-1 relative to isotype controls was
determined by flow cytometry. Wild-type RW4 line, dashed line;Hox deficiency in Mll/ EBs, normal cell accumulation
average of two independent Mll/ ES cell clones, blue lines; andand development of some early hematopoietic popula-
average of two independent Mll/ clones, red lines. Error barstions occurs (Figures 1, 2A, and 2B). However, the sub-
reflect the standard deviation between duplicate samples for the
sequent development of hematopoietic-restricted, clo- Mll / and Mll/ EBs.
nogenic progenitors is sharply reduced in the absence
of MLL. Although the full MLL-dependent gene program
is likely to extend beyond the genes assessed here, we
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Figure 2. Development of Hematopoietic Populations in Mll-Deficient and Control EBs
(A) Development of the c-Kit/CD41 cells in Mll/ (top row) and Mll/ EBs (bottom row). ES cell clones were differentiated for the number
of days indicated below the plots and dissociated with collagenase/dispase, and single-cell suspensions were analyzed by flow cytometry.
Similar results were obtained with three different pairs of Mll/ and Mll/ clones.
(B) Percentages of c-Kit /CD41cells in day 6 EBs. Analysis was performed as described above for eight independent experiments. Individual
values are represented as black triangles, and red bars reflect the average of eight experiments.
(C) Hematopoietic-colony frequency is reduced within the Mll-deficient c-Kit/CD41 population. EB cultures were harvested as described
in panel (B). c-Kit/CD41 cells were sorted, plated in duplicate, and scored as described in the Experimental Procedures. The graph represents
the average of total colonies from duplicate cultures. Similar results were obtained with three different pairs of Mll/ and Mll/ clones. Mac,
macrophage colonies; GM, granulocyte-macrophage colonies; and BFU-E, burst-forming units, erythroid.
tested whether Hox genes would prove to be critical Because the expression of multiple Hox genes was
reduced, we first attempted to rescue Mll/ colonydownstream effectors of MLL at this point in hematopoi-
etic development. growth by utilizing Kugelig (Cdx4 in the mouse), a posi-
tive regulator of Hox genes. Normally, Cdx4 expression
peaks during day 3–4 of EB differentiation, but reexpres-Rescue of Progenitor Frequency in Mll/ EBs
Because Mll-deficient EBs produce normal numbers of sion in day 6 EB-derived progenitors results in the acti-
vation of Hoxa6, Hoxa9, Hoxb3, Hoxb4, Hoxb8, andviable c-Kit/CD41 cells, we reasoned that this com-
mitted hematopoietic population would be ideal for test- Hoxc6 ([23] and Figure S3). Cdx4 expression in control
EB cells enhanced the frequency of hematopoietic colo-ing putative downstream effectors of MLL. We intro-
duced candidate genes into CD41-enriched Mll/ and nies, in particular granulocyte-macrophage colonies
(Figure 4B). Notably, expression of Cdx4 in Mll-deficientMll/ control EB cells by retroviral transduction to as-
sess their capacity to rescue hematopoietic-colony fre- progenitors resulted in a marked increase in hematopoi-
etic-colony frequency, restoring colony numbers to thequency within this population (Figure 4A).
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Figure 3. Gene Expression Differences during EB Differentiation
(A–L) Mll/ (green bars) and Mll/ EBs (red bars) were harvested daily for 10 days, and cDNA was prepared from total RNA. The resulting
cDNA samples were subjected to real-time PCR analyses to detect the genes indicated above each graph. The values on the y axis represent
relative transcript levels normalized to GAPDH for all reactions except those shown in panels (E), (J), and (L), for which actin served as the
reference gene. For primer and probe sequences, see Figure S4. The values reflect averages of triplicate samples expressed in arbitrary units
with the lowest normalized value defined as 1.
level of control GFP-transduced cells (Figure 4B). The quency within Mll/ cells expressing Hoxa9, Hoxa10,
or Hoxb4 (and to a lesser extent Hoxb3) was restored todegree of rescue was similar to that observed when
MLL was reintroduced by knock-in of the human MLL the level of control cells (Figures 5A and 5B). In contrast,
Pitx2, an MLL-dependent homeodomain gene, could notcDNA (unpublished data).
Next, we tested whether single Hox genes were capa- significantly rescue colony frequency in Mll/ EB cells,
although it did influence the distribution of colony typesble of rescuing hematopoietic colony growth by trans-
ducing Mll/ EB cells with Hoxa9, Hoxa10, Hoxb3, or (Figure 5B). Although the rescue of colony frequency
was a common feature of the Hox genes tested, subse-Hoxb4 individually. Remarkably, the total colony fre-
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that involves more than protection from apoptosis. One
can replace this particular function of MLL by increasing
Hox gene levels through Cdx4 expression or by reex-
pressing individual HoxA or HoxB cluster genes, but
not the non-Hox homeodomain gene Pitx2. Surprisingly,
expression of a single Mll target gene (representative
of either Antennapedia or Abdominal B class Hox genes)
is sufficient to promote clonogenic growth and differen-
tiation of hematopoietic colonies in the absence of MLL.
The rescue of Mll (this study) and Kugelig mutants
[23] by individual Hox gene reexpression suggests that
a common Hox gene function may be required for the
proliferative expansion of early hematopoietic progeni-
tors, which can be replaced by overexpression of a sin-
gle Hox gene. Loss-of-function experiments demon-
strate that redundancy among Hox genes of a paralog
group is observed for skeletal patterning [28–30] and
organogenesis [31]. A redundant role of Drosophila Hox
proteins was also noted in the regulation of abdominal
neuroblast progenitor pool size [32]. We propose that
expression of individual Hox genes in Mll/ hematopoi-
etic progenitors results in a stereotypic response to Hox
proteins; this response likely involves proliferation in this
cell context (Figure 5E). Members of several different
paralog groups (3, 4, 9, and 10) representing both Antp-
Figure 4. Cdx4 Expression Rescues Hematopoietic-Colony Fre- type and Abd-B-type Hox genes rescued hematopoie-
quency in Mll/ Progenitors toc-colony frequency, reflecting a common function of
(A) Scheme for introducing genes into EB-derived hematopoietic these Hox genes in promoting hematopoietic growth.
cells and quantification of progenitor frequency. Day 6 embryoid
However, continued Hox expression in these cells re-body cells were enriched for CD41 cells, plated on the OP9 stromal
vealed that subsequent differentiation (Figures 5D andline, and infected with a GFP-expressing bicistronic retrovirus. GFP
5E) is influenced by the specific Hox gene expressed.cells were then plated in methylcellulose cultures, and colonies were
scored as described in the Experimental Procedures. Furthermore, our data supports the concept that the
(B) Rescue of Mll/ hematopoietic colonies by Cdx4. EB cells of global reduction in Hox gene expression in the Mll mu-
the genotype shown below each set of bars were manipulated as tant is the primary defect leading to a block in hemato-
described in (A). Five thousand GFP cells transduced with the virus
poiesis (Figure 5E). This model predicts that membersindicated below each bar were plated as described above. Error
of a common set of hematopoietic growth-promotingbars represent the standard deviation for total colonies. GEMM,
genes are both reduced in Mll-deficient cells and in-granulocyte-macrophage-erythroid-megakaryocyte colonies; Mac,
macrophage colonies; GM, granulocyte-macrophage colonies; creased in cells overexpressing the Hox genes tested
BFU-E, burst-forming units, erythroid; and Meg-Mix, mixed colonies here, a hypothesis that we are currently testing.
containing megakaryocytes.
Experimental Procedures
Cell Culturequent differentiation was influenced by the specific Hox
The RW4 ES line was cultured and targeted sequentially to producegene expressed (e.g., Hoxa9 yields predominantly Mac-
Mll/ clones as described [2]. Embryonic stem cell and embryoid
1/Gr-1 cells, whereas Hoxb4 cells are predominantly body cultures were performed by standard methods, with specific
Mac-1neg/Gr-1neg/c-Kit, Figure 5D and unpublished conditions as described in the Supplemental Data.
data).
Intrinsic protection from apoptosis plays an important Purification and Manipulation of Transitional Populations
role during hematopoietic development [24, 25]. Ectopic Cell percentages were determined by flow cytometry with the APC-
c-Kit (clone 2B8) and FITC-CD41 antibodies from Pharmingen. ForBCL-2 expression has been shown to enhance steady-
retroviral infection, cells were enriched with FITC-labeled anti-CD41state HSC numbers and clonogenic frequency in vitro
and anti-FITC magnetic particles (Militenyi) as described by the[26]. In AGM-derived cells, BCL-2 expression also en-
manufacturer, resulting in a 5- to 10-fold enrichment of CD41 cells.
hances recipient reconstitution [27]. We asked whether After enrichment, cells were spin infected and then plated on OP9
the expression of an anti-apoptotic molecule would be monolayers [33], and a second infection was performed in the 6-well
sufficient to rescue colony frequency in MLL-deficient dish after 1 day. After 2 days total growth, GFP small hematopoietic
cells were sorted and plated in cytokine-containing methylcelluloseprogenitors. BCL-2 expression did not increase the fre-
medium. Colonies were scored after 7–8 days.quency of colony-forming cells within Mll-deficient pro-
genitors, consistent with the observation that spontane-
Retroviral Constructsous levels of apoptosis did not differ between Mll/
The MSCV-based Hoxa10, Hoxb3, and Hoxb4 retrovirus plasmidsand control EB cells (unpublished data).
were gifts from Keith Humphries (B.C. Cancer Agency), MSCV-
Taken together, these results demonstrate that MLL Pitx2c-iresGFP retrovirus was from Bernard Forget (Yale University),
promotes the growth of hematopoietic progenitors sub- and the murine Cdx4 cDNA was from Chris Wright (Vanderbilt Uni-
versity). MSCV-Cdx4 was constructed by PCR amplification of thesequent to hematopoietic commitment by a mechanism
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Figure 5. Rescue of Mll/ Hematopoietic-Colony Frequency
(A) Rescue of Mll/ hematopoietic-colony frequency by Hox genes. The Mll/- and Mll/-GFP-transduced colony data are reproduced from
Figure 4B. Colony abbreviations are as in Figure 4.
(B) Pitx2 expression does not rescue Mll/ hematopoietic-colony frequency. Hoxb3 and Hoxb4 serve as positive controls for this experiment.
(C) BCL-2 expression does not rescue Mll/ colony frequency. Hoxa9 serves as a positive control for this experiment. Cells were transduced
and scored as described in Figure 4.
(D) Flow-cytometric analysis of cells from methylcellulose cultures. Both Mll/ and Mll/ EB cells were transduced with the viruses indicated
above each column of FACS plots. Colonies quantified in the experiments above were allowed to grow for seven additional days after scoring,
and cells were harvested and analyzed with anti-CD11b (Mac-1, y axis) and anti-Gr-1 (x axis) antibodies. All data shown are representative
of at least five experiments performed in duplicate or triplicate.
(E) Model depicting the roles of Mll and Hox genes during hematopoietic development. The patterning of mesoderm by Hox gene expression
is depicted as resulting in the production of hematopoietic progenitors indicated by the c-Kit/CD41 cells. Subsequently, the proliferative
expansion of these cells is then dependent on the redundant Hox activity described in the Discussion; this is the point at which Mll is critical
for maintaining appropriate levels of Hox gene expression (indicated by “Mll deficiency”). Subsequent differentiation is then influenced by the
unique features of the particular Hox gene expressed in the studies described here.
approximately 1 kb open reading frame, which was then inserted tems) for Figure 3 panels (A)–(D), (F)–(I), and (K). Test gene CT values
were normalized to GAPDH CT values, and relative expression levelsinto the retroviral plasmid at EcoRI and XhoI sites. The human Hoxa9
cDNA was a gift from Adolfo Ferrando (Dana Farber Cancer Institute) were derived with the comparative CT method [35]. For Figure 3
panels (E), (J), and (L), SYBR Green reagents (Applied Biosystems)and was inserted into the MSCV plasmid used above as a BamHI-
StuI fragment. The human BCL-2 cDNA was excised from plasmid were used to detect the test gene, and actin PCR reactions were
performed separately in triplicate for normalization. For detailedpcDNA3hBCL2-3336 [34] and was inserted into the MSCV backbone
as an EcoRI fragment. BCL-2 protein expression was confirmed by methods, primer and probe sequences, see Supplemental Experi-
mental Procedures and Figure S4.transient expression in 293 cells.
Quantitative Gene Expression Analyses
cDNA prepared from embryoid-body total RNA was subjected to Supplemental Data
Supplemental Experimental Procedures and four additional figuresreal-time PCR reactions performed in triplicate with an ABI Prism
7700 Sequence Detector. Multiplex reactions were performed with are available with this article online at http://www.current-biology.
com/cgi/content/full/14/22/2063/DC1/.rodent GAPDH VIC-labeled probe and primer sets (Applied Biosys-
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